Articles

Results 1 to 5 of 8


Recent Developments in Patent Law: Non-Obviousness of Chemical and Pharmaceutical Patents

USA - August 26 2020 Join a discussion on recent developments in patent law, particularly the non-obviousness of chemical and pharmaceutical patents. During the…

Justin J. Hasford

Recent Developments in Patent Law: Non-Obviousness of Pharmaceutical Formulations

USA - August 29 2019 The development of pharmaceutical products is often expensive and unpredictable. Researchers investing the time and resources to develop a novel and…

Justin J. Hasford, Andrew E. Renison

FDA Draft Guidance on Submitting Documents Using Real-World Data and Real-World Evidence

USA - May 17 2019 On May 8, 2019, FDA issued draft guidance for the submission of documents using real-world data (RWD) and real-world evidence (RWE) to FDA for drugs…

FDA Final Guidance on Application of Statutory Factors in Determining When a REMS is Necessary

USA - April 11 2019 On April 4, 2019, FDA issued final guidance on FDA’s application of the statutory factors in determining when a risk evaluation and mitigation…

The Internet of Things: Divided Infringement

USA - November 10 2016 Some analysts predict the Internet of Things (IoT) market will grow from nearly $2 trillion in 2013 to $7 trillion in 2020. With this rapid growth…